Specialties We Serve View All →

Home › Blog

Gastroenterology Billing Services

Billing a Colonoscopy After a Positive Cologuard or FIT: KX, 33, PT and Diagnosis Sequencing

Colonoscopy billing after a positive Cologuard or FIT test with KX, 33, and PT modifiers

A positive stool test used to turn the next colonoscopy into a diagnostic procedure with a patient bill. That is no longer the rule. Today, a colonoscopy after positive Cologuard or FIT results is the second step of one screening, so Medicare and most commercial plans cover it without deductible or coinsurance.

The modifiers carry that message to the payer. Medicare wants KX on G0105 or G0121, or PT on the CPT code when a polyp is removed. Commercial plans generally use modifier 33. Meanwhile, the diagnosis order, with Z12.11 first and R19.5 second, keeps every related claim in screening status.

Why the Follow-On Colonoscopy Is Still Screening

Medicare now treats the stool test and a colonoscopy after positive Cologuard or FIT results as one complete screening. As a result, neither step carries a deductible or coinsurance, and normal screening frequency limits do not apply to the follow-on procedure. The latest CMS transmittal on colorectal screening confirms this rule for stool-based tests from January 1, 2023, and for approved blood-based tests from January 1, 2025.

The stool tests that trigger the rule include:

  • Cologuard, the positive stool DNA test 81528
  • FIT, billed as G0328 for Medicare
  • Guaiac-based FOBT, billed as 82270

Commercial plans follow a similar rule under federal preventive care guidance. However, a colonoscopy ordered for symptoms such as bleeding or anemia is still diagnostic, even after a recent stool test. For the wider difference between the two, see our post on screening vs diagnostic colonoscopy.

Medicare Claims: When to Use KX or PT

On a Medicare claim, what happened during the procedure decides between KX and PT.

For a pure screening with no biopsy or polyp removal, use the follow-on colonoscopy KX modifier: G0105-KX for a high-risk patient or G0121-KX for average risk. As the AGA explains, KX tells Medicare the colonoscopy follows a positive stool test.

When a polyp is removed or a biopsy is taken, report the CPT code instead, such as 45380 or 45385, applying the PT modifier polypectomy screening rule to each one. Our guide to 45380 vs 45385 covers that code choice.

With PT, the deductible is waived, but coinsurance is 15% through 2026, 10% from 2027 to 2029 and zero in 2030.

Commercial Plans and Modifier 33

Most commercial plans skip the G codes and expect the CPT code with modifier 33, which marks a preventive service with no cost-sharing.

Federal guidance from 2022 requires non-grandfathered plans to cover the follow-up colonoscopy after a positive stool test as screening. So a modifier 33 commercial follow-on colonoscopy claim reads 45378-33, or 45385-33 when a polyp is removed.

Unlike Medicare, these plans usually keep polyp removal in screening status. Still, policies vary, so check each plan’s screening rules before the first claim.

Quick Modifier Matrix by Payer and Finding

The right line depends on two facts: who pays, and whether tissue was removed. This matrix pulls the rules together, from the G0105 G0121 KX pairing to the commercial 33 lines.

PayerNo polyp removedPolyp or biopsy
MedicareG0121-KX or G0105-KX45385-PT or 45380-PT
Medicare AdvantageUsually KX, like MedicareUsually PT; check plan
Commercial45378-3345385-33 or 45380-33

When more than one procedure is done, such as a biopsy and a snare polypectomy, each CPT code gets its own PT or 33 modifier.

Diagnosis Order After a Positive Stool Test

The diagnosis order must tell the same screening story as the modifiers. For Z12.11 R19.5 sequencing, list Z12.11, colon cancer screening, first, then R19.5 for the positive stool result.

The same order applies to FIT positive colonoscopy coding and to a positive Cologuard. Add any risk factor, such as family history, which also supports G0105 for Medicare.

List any polyp finding after the screening codes. Leading with the polyp or R19.5 can make the claim look diagnostic and trigger a bill the patient should not owe.

Keeping Related Claims in Screening Status

One colonoscopy can produce three or four claims. If only the physician claim is coded as screening, the patient may still get bills from the others.

The Anesthesia Claim

For Medicare, anesthesia with a screening colonoscopy is reported as 00812, with no deductible or coinsurance. If the procedure becomes diagnostic, the anesthesia line changes to 00811 with the PT modifier. Commercial plans usually expect 00812 with modifier 33. Our guide to anesthesia physical status modifiers covers the other modifiers on that claim.

The Facility Claim

The surgery center or hospital bills the same procedure code as the physician, with the same KX, PT or 33 modifier. A mismatch between the two claims often leaves one of them processed as diagnostic.

The Pathology Claim

When tissue is removed, the pathologist bills separately for the specimen. Sending the pathologist the screening diagnosis order, with Z12.11 first, helps that claim follow the same screening logic, though payer rules for pathology vary.

Returned Claims and Denials to Watch For

The most common problem is a CARC 16 N822 KX denial: the claim lacks information, and the missing piece is the KX modifier on G0105 or G0121. Add KX and resubmit; there is nothing to appeal.

A related code, N823, flags an invalid modifier. Usually KX was placed on a CPT code instead of the G code, or PT and KX were mixed on one line.

A third pattern bills the patient instead of denying. When R19.5 or a polyp code leads, or the anesthesia or facility claim lacks the modifier, the payer may process it as diagnostic. A corrected claim with screening coding fixes it.

In busy GI practices, these returns add up fast, as our post on high-volume colonoscopy claims shows.

Scheduling Steps That Prevent Surprise Bills

Correct coding starts before the procedure date, when the order and the patient’s history are still easy to confirm.

  1. Capture the stool test result. Before scheduling a colonoscopy after positive Cologuard or FIT results, save the dated report in the chart.
  2. Confirm there are no symptoms. If the order mentions bleeding, pain or anemia, the colonoscopy is diagnostic, and the patient should hear that up front.
  3. Flag the visit as a follow-on screening. A scheduling note tells the coding team to use KX, PT or 33 and to sequence Z12.11 first.
  4. Explain polyp costs to Medicare patients. If a polyp is removed in 2026, a 15% coinsurance can still apply, so a short conversation now avoids a complaint later.
  5. Share the plan with the anesthesia group and facility. Each one needs the same screening codes on its own claim.

What the Patient Should Owe After a Positive Stool Test

For most patients, the honest answer is nothing, or very little. A colonoscopy after positive Cologuard or FIT results finishes a screening the patient already started, and the rules now reflect that. The only common exception is Medicare coinsurance on polyp removal, which shrinks each year until it disappears in 2030.

When a patient still receives a bill, the cause is almost always on the claim side: a missing KX, a 33 left off the anesthesia line, or R19.5 listed ahead of Z12.11. Those are fixable details, and catching them early protects both collections and patient trust. Teams that want a second review of these claims can lean on GI billing specialists who track screening rules as they change.

Colonoscopy After Positive Cologuard FAQs

Is a colonoscopy after a positive Cologuard test screening or diagnostic?

It is screening for Medicare and most commercial plans, as long as the patient has no new symptoms. It completes the screening the stool test started.

Which modifier does Medicare require?

KX on G0105 or G0121 when no polyp is removed. When a polyp is removed or a biopsy is taken, use the CPT code with PT instead.

What diagnosis codes should be used?

Z12.11 first, then R19.5 for the positive stool result, followed by any risk factors or findings.

Do patients pay anything if a polyp is removed?

Under Medicare, the deductible is waived, but 15% coinsurance applies in 2026. It drops to 10% from 2027 to 2029 and to zero in 2030.

What does CARC 16 with N822 mean on these claims?

The claim is missing a required modifier, usually KX on G0105 or G0121. Add it and resubmit.

GET STARTED

Ready to Transform Your Revenue Cycle?

To learn more about how we can help you transform your revenue cycle, contact us by filling out an online form, by phone at +1 (214) 252 7994, or by email at info@mbwrcm.com.

Schedule a 30-minute call. We’ll assess your current state and show you what’s achievable.

    Your information will be securely sent to and stored in Google Sheets for the purpose of processing your form submission.
    Schedule a free demo Receive a customized quote built around your specialty, volume and payer mix. A revenue cycle specialist will respond within 12 hours.